Cargando…
Biglycan and reduced glycolysis are associated with breast cancer cell dormancy in the brain
Exit of quiescent disseminated cancer cells from dormancy is thought to be responsible for metastatic relapse and a better understanding of dormancy could pave the way for novel therapeutic approaches. We used an in vivo model of triple negative breast cancer brain metastasis to identify differences...
Autores principales: | Sunderland, Ashley, Williams, Jennifer, Andreou, Tereza, Rippaus, Nora, Fife, Christopher, James, Fiona, Kartika, Yolanda Dyah, Speirs, Valerie, Carr, Ian, Droop, Alastair, Lorger, Mihaela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339804/ https://www.ncbi.nlm.nih.gov/pubmed/37456245 http://dx.doi.org/10.3389/fonc.2023.1191980 |
Ejemplares similares
-
Hematopoietic Stem Cell Gene Therapy for Brain Metastases Using Myeloid Cell–Specific Gene Promoters
por: Andreou, Tereza, et al.
Publicado: (2019) -
Metastatic site-specific polarization of macrophages in intracranial breast cancer metastases
por: Rippaus, Nora, et al.
Publicado: (2016) -
Immune Checkpoint Blockade – How Does It Work in Brain Metastases?
por: Lorger, Mihaela, et al.
Publicado: (2019) -
The Role of Decorin and Biglycan Signaling in Tumorigenesis
por: Diehl, Valentina, et al.
Publicado: (2021) -
Biglycan regulates bone development and regeneration
por: Shainer, Reut, et al.
Publicado: (2023)